Mechanistic modeling of the effects of glucocorticoids and circadian rhythms on adipokine expression

Journal of Pharmacology and Experimental Therapeutics

Volumn 337, Issue 3, 2011, Pages 734-746

  Sukumaran, Siddharth ^a   Jusko, William J ^a   DuBois, Debra C ^a   Almon, Richard R ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; FATTY ACID; GLUCOCORTICOID RECEPTOR; GLUCOSE; INSULIN; LEPTIN; MESSENGER RNA; METHYLPREDNISOLONE SODIUM SUCCINATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; COMPARTMENT MODEL; CONTROLLED STUDY; DOWN REGULATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG MECHANISM; FATTY ACID BLOOD LEVEL; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE SYNTHESIS; INSULIN BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT;

ADIPONECTIN; ADIPOSE TISSUE, WHITE; ANIMALS; BLOOD GLUCOSE; CIRCADIAN RHYTHM; DOWN-REGULATION; FATTY ACIDS, NONESTERIFIED; GLUCOCORTICOIDS; INSULIN; LEPTIN; MALE; METHYLPREDNISOLONE; MODELS, BIOLOGICAL; RATS; RATS, WISTAR; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER;

EID: 79956226689     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.179960     Document Type: Article

References (40)

1. Ahima RS and Flier JS (2000) Adipose tissue as an endocrine organ. Trends Endocrinol Metab 11:327-332.
2. Arola L, Palou A, Remesar X, Herrera E, and Alemany M (1980) Effect of stress and sampling site on metabolite concentration in rat plasma. Arch Int Physiol Biochim 88:99-105. (Pubitemid 11244643)
3. Beato M, Chalepakis G, Schauer M, and Slater EP (1989) DNA regulatory elements for steroid hormones. J Steroid Biochem 32:737-747.
4. Bialas MC and Routledge PA (1998) Adverse effects of corticosteroids. Adverse Drug React Toxicol Rev 17:227-235. (Pubitemid 29123597)
5. Boden G, Ruiz J, Urbain JL, and Chen X (1996) Evidence for a circadian rhythm of insulin secretion. Am J Physiol Endocrinol Metab 271:E246-E252.
6. Cabanelas A, Cordeiro A, Santos Almeida NA, Monteiro de Paula GS, Coelho VM, Ortiga-Carvalho TM, and Pazos-Moura CC (2010) Effect of triiodothyronine on adiponectin expression and leptin release by white adipose tissue of normal rats. Horm Metab Res 42:254-260.
7. D'Argenio D, Schumitzky A and Wang X (2009) ADAPT 5 User's Guide: Pharmacokinetic/ Pharmacodynamic Systems Analysis Software (Biomedical Simulations Resource, Los Angeles, CA).
8. Fantuzzi G (2008) Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol 121:326-330.
9. Haché RJ, Tse R, Reich T, Savory JG, and Lefebvre YA (1999) Nucleocytoplasmic trafficking of steroid-free glucocorticoid receptor. J Biol Chem 274:1432-1439.
10. Hanson RW and Reshef L (1997) Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu Rev Biochem 66:581-611. (Pubitemid 27274668)
11. Hazra A, Krzyzanski W, and Jusko WJ (2006) Mathematical assessment of properties of precursor-dependent indirect pharmacodynamic response models. J Pharmacokinet Pharmacodyn 33:683-717. (Pubitemid 44819258)
12. Hazra A, Pyszczynski NA, DuBois DC, Almon RR, and Jusko WJ (2008) Modeling of corticosteroid effects on hepatic low-density lipoprotein receptors and plasma lipid dynamics in rats. Pharm Res 25:769-780. (Pubitemid 351661827)
13. Jahng JW, Kim NY, Ryu V, Yoo SB, Kim BT, Kang DW, and Lee JH (2008) Dexamethasone reduces food intake, weight gain and the hypothalamic 5-HT concentration and increases plasma leptin in rats. Eur J Pharmacol 581:64-70.
14. Jang C, Inder WJ, Obeyesekere VR, and Alford FP (2008) Adiponectin, skeletal muscle adiponectin receptor expression and insulin resistance following dexamethasone. Clin Endocrinol (Oxf) 69:745-750.
15. Jin JY and Jusko WJ (2009) Pharmacodynamics of glucose regulation by methylprednisolone. I. Adrenalectomized rats. Biopharm Drug Dispos 30:21-34.
16. Kalsbeek A, Fliers E, Romijn JA, La Fleur SE, Wortel J, Bakker O, Endert E, and Buijs RM (2001) The suprachiasmatic nucleus generates the diurnal changes in plasma leptin levels. Endocrinology 142:2677-2685. (Pubitemid 32473125)
17. Karmazyn M, Purdham DM, Rajapurohitam V, and Zeidan A (2007) Leptin as a cardiac hypertrophic factor: a potential target for therapeutics. Trends Cardiovasc Med 17:206-211. (Pubitemid 47089011)
18. Krzyzanski W, Chakraborty A, and Jusko WJ (2000) Algorithm for application of Fourier analysis for biorhythmic baselines of pharmacodynamic indirect response models. Chronobiol Int 17:77-93. (Pubitemid 30078523)
19. La Fleur SE, Kalsbeek A, Wortel J, and Buijs RM (1999) A suprachiasmatic nucleus generated rhythm in basal glucose concentrations. J Neuroendocrinol 11:643-652. (Pubitemid 29338681)
20. Landersdorfer CB and Jusko WJ (2008) Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus. Clin Pharmacokinet 47:417-448. (Pubitemid 351861956)
21. Matarese G, Moschos S, and Mantzoros CS (2005) Leptin in immunology. J Immunol 174:3137-3142. (Pubitemid 40354011)
22. Miell JP, Englaro P, and Blum WF (1996) Dexamethasone induces an acute and sustained rise in circulating leptin levels in normal human subjects. Horm Metab Res 28:704-707. (Pubitemid 27057920)
23. Mlinar B, Marc J, Janez A, and Pfeifer M (2007) Molecular mechanisms of insulin resistance and associated diseases. Clin Chim Acta 375:20-35.
24. Murakami T, Iida M, and Shima K (1995) Dexamethasone regulates obese expression in isolated rat adipocytes. Biochem Biophys Res Commun 214:1260-1267.
25. Nicod N, Giusti V, Besse C, and Tappy L (2003) Metabolic adaptations to dexamethasone- induced insulin resistance in healthy volunteers. Obes Res 11:625-631. (Pubitemid 41151613)
26. Oakley RH and Cidlowski JA (1993) Homologous down regulation of the glucocorticoid receptor: the molecular machinery. Crit Rev Eukaryot Gene Expr 3:63-88. (Pubitemid 23163668)
27. Raff H and Bruder ED (2006) Adiponectin and resistin in the neonatal rat: effects of dexamethasone and hypoxia. Endocrine 29:341-344. (Pubitemid 44097376)
28. Rees DA and Alcolado JC (2005) Animal models of diabetes mellitus. Diabet Med 22:359-370. (Pubitemid 40516231)
29. Schaaf MJ and Cidlowski JA (2002) Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol 83:37-48. (Pubitemid 37040640)
30. Schäcke H, Döcke WD, and Asadullah K (2002) Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96:23-43.
31. Shi JH, Du WH, Liu XY, Fan YP, Hu XL, Zhou HY, Xu HB, Zhang XM, Xiang P, and Chen FL (2010) Glucocorticoids decrease serum adiponectin level and WAT adiponectin mRNA expression in rats. Steroids 75:853-858.
32. Sukumaran S, Almon RR, DuBois DC, and Jusko WJ (2010a) Circadian rhythms in gene expression: Relationship to physiology, disease, drug disposition and drug action. Adv Drug Deliv Rev 62:904-917.
33. Sukumaran S, Xue B, Jusko WJ, Dubois DC, and Almon RR (2010b) Circadian variations in gene expression in rat abdominal adipose tissue and relationship to physiology. Physiol Genomics 42A:141-152.
34. Wang P, Mariman E, Renes J, and Keijer J (2008) The secretory function of adipocytes in the physiology of white adipose tissue. J Cell Physiol 216:3-13. (Pubitemid 351813090)
35. Wang Q, Bing C, Al-Barazanji K, Mossakowaska DE, Wang XM, McBay DL, Neville WA, Taddayon M, Pickavance L, Dryden S, et al. (1997) Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes 46:335-341.
36. Xu A, Wong LC, Wang Y, Xu JY, Cooper GJ, and Lam KS (2004) Chronic treatment with growth hormone stimulates adiponectin gene expression in 3T3-L1 adipocytes. FEBS Lett 572:129-134. (Pubitemid 39092524)
37. Xu C, He J, Jiang H, Zu L, Zhai W, Pu S, and Xu G (2009) Direct effect of glucocorticoids on lipolysis in adipocytes. Mol Endocrinol 23:1161-1170.
38. Yao Z, DuBois DC, Almon RR, and Jusko WJ (2006) Modeling circadian rhythms of glucocorticoid receptor and glutamine synthetase expression in rat skeletal muscle. Pharm Res 23:670-679.
39. Yuan J (1993) Modeling blood/plasma concentrations in dosed feed and dosed drinking water toxicology studies. Toxicol Appl Pharmacol 119:131-141.
40. Zeng J, Patterson BW, Klein S, Martin DR, Dagogo-Jack S, Kohrt WM, Miller SB, and LandtM(1997) Whole body leptin kinetics and renal metabolism in vivo. Am J Physiol Endocrinol Metab 273:E1102-E1106.